Literature DB >> 18930020

Insight into the role of HSPG in the cellular uptake of apolipoprotein E-derived peptide micelles and liposomes.

Eik Leupold1, Heike Nikolenko, Michael Beyermann, Margitta Dathe.   

Abstract

Liposomes and micellar carriers equipped with targeting and cellular uptake mediating peptides have attracted attention for numerous applications. The optimization of the carrier requires an understanding of how their properties influence target cell recognition and uptake. We developed a dipalmitoylated apolipoprotein E-derived peptide, named P2A2 as promising vector to mediate cellular uptake of potential micellar and liposomal carriers. Confocal laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS) were used to get insight into the internalization mediated by carboxyfluoresceine-labeled P2fA2 and the all-D amino acid analogue P2fa2 into brain capillary endothelial cells. Both peptide micelles and liposomes entered cells via endocytosis. Cell surface heparan sulfate proteoglycans (HSPGs) were involved in the internalization process of peptide-bearing liposomes characterized by a diameter of 100 nm, a low surface density of 100 peptide molecules per vesicle and a helical conformation of the vector. In contrast, peptide micelles characterized by a diameter of about 10 nm, a high peptide density caused by 19 associated molecules and a high conformational flexibility of the vector sequence did not address HSPG. Unspecific interactions between the carriers and membrane constituents predominate the two uptake processes but stereospecific components seem to be involved. Both routes differ with respect to transport efficiency. The results provide a prospective basis to optimize liposomes and micelles as drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930020     DOI: 10.1016/j.bbamem.2008.09.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.

Authors:  Karin Aufenvenne; Fernando Larcher; Ingrid Hausser; Blanca Duarte; Vinzenz Oji; Heike Nikolenko; Marcela Del Rio; Margitta Dathe; Heiko Traupe
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

Review 2.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

Review 3.  Molecular Sensing with Host Systems for Hyperpolarized 129Xe.

Authors:  Jabadurai Jayapaul; Leif Schröder
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

4.  Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model.

Authors:  Sylvia Wagner; Anja Zensi; Sascha L Wien; Sabrina E Tschickardt; Wladislaw Maier; Tikva Vogel; Franz Worek; Claus U Pietrzik; Jörg Kreuter; Hagen von Briesen
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

5.  Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury.

Authors:  Li Shan Chiu; Ryan S Anderton; Jane L Cross; Vince W Clark; Adam B Edwards; Neville W Knuckey; Bruno P Meloni
Journal:  Transl Neurosci       Date:  2017-11-15       Impact factor: 1.757

6.  Heparan sulfate proteoglycan-mediated dynamin-dependent transport of neural stem cell exosomes in an in vitro blood-brain barrier model.

Authors:  Bhagyashree S Joshi; Inge S Zuhorn
Journal:  Eur J Neurosci       Date:  2020-09-30       Impact factor: 3.386

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.